Naoki Horikawa
Papers
1
Total Citations
2
H-Index
1
About
Naoki Horikawa is a clinician-researcher whose work centers on the early detection and management of gynecologic cancers, with a particular focus on Lynch syndrome—a hereditary condition that significantly elevates cancer risk. His most-cited case report, “Endometrial Cancer Diagnosed at an Early Stage during Lynch Syndrome Surveillance” (2023), underscores a critical contribution: demonstrating the real-world efficacy of annual transvaginal ultrasonography and endometrial biopsy in catching endometrial cancer at its most treatable stage in high-risk patients. This work not only reinforces the value of rigorous surveillance protocols but also provides a practical, patient-centered model for managing Lynch syndrome-associated malignancies. Though early in his career, Horikawa’s findings have already garnered attention, with his landmark paper cited twice—a meaningful start that highlights the growing interest in hereditary cancer prevention. His research bridges the gap between genetic predisposition and actionable clinical screening, offering hope for improved outcomes in at-risk populations. For students and researchers, Horikawa’s work serves as a compelling example of how targeted surveillance can transform the prognosis of inherited cancers, making him a rising voice in the field of gynecologic oncology and cancer genetics.
Research Focus
Key Achievements
Top Papers
- 1